183 related articles for article (PubMed ID: 12175339)
1. Classifying the medulloblastoma: insights from morphology and molecular genetics.
Ellison D
Neuropathol Appl Neurobiol; 2002 Aug; 28(4):257-82. PubMed ID: 12175339
[TBL] [Abstract][Full Text] [Related]
2. Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients.
Lamont JM; McManamy CS; Pearson AD; Clifford SC; Ellison DW
Clin Cancer Res; 2004 Aug; 10(16):5482-93. PubMed ID: 15328187
[TBL] [Abstract][Full Text] [Related]
3. Molecular Classification of Medulloblastoma.
Kijima N; Kanemura Y
Neurol Med Chir (Tokyo); 2016 Nov; 56(11):687-697. PubMed ID: 27238212
[TBL] [Abstract][Full Text] [Related]
4. Molecular Classification of Medullobastomas by Whole Genome Expression Profiling.
Nosková H; Adamcová S; Knoflíčková LDR; Pavelka Z; Vejmělková K; Zitterbart K; Slabý O; Štěrba J
Klin Onkol; 2019; 32(Supplementum1):171-173. PubMed ID: 31064192
[TBL] [Abstract][Full Text] [Related]
5. Update on the integrated histopathological and genetic classification of medulloblastoma - a practical diagnostic guideline.
Pietsch T; Haberler C
Clin Neuropathol; 2016; 35(6):344-352. PubMed ID: 27781424
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas.
Kaur K; Kakkar A; Kumar A; Purkait S; Mallick S; Suri V; Sharma MC; Julka PK; Gupta D; Suri A; Sarkar C
J Neurooncol; 2016 Dec; 130(3):423-430. PubMed ID: 27576698
[TBL] [Abstract][Full Text] [Related]
7. Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas.
McManamy CS; Lamont JM; Taylor RE; Cole M; Pearson AD; Clifford SC; Ellison DW;
J Neuropathol Exp Neurol; 2003 Jun; 62(6):627-32. PubMed ID: 12834107
[TBL] [Abstract][Full Text] [Related]
8. Nodule formation and desmoplasia in medulloblastomas-defining the nodular/desmoplastic variant and its biological behavior.
McManamy CS; Pears J; Weston CL; Hanzely Z; Ironside JW; Taylor RE; Grundy RG; Clifford SC; Ellison DW;
Brain Pathol; 2007 Apr; 17(2):151-64. PubMed ID: 17388946
[TBL] [Abstract][Full Text] [Related]
9. Medulloblastoma: what is the role of molecular genetics?
Entz-Werle N; Carli ED; Ducassou S; Legrain M; Grill J; Dufour C
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1169-81. PubMed ID: 18588461
[TBL] [Abstract][Full Text] [Related]
10. Integrating Molecular Subclassification of Medulloblastomas into Routine Clinical Practice: A Simplified Approach.
Kaur K; Kakkar A; Kumar A; Mallick S; Julka PK; Gupta D; Suri A; Suri V; Sharma MC; Sarkar C
Brain Pathol; 2016 May; 26(3):334-43. PubMed ID: 26222673
[TBL] [Abstract][Full Text] [Related]
11. Pathology, diagnostics, and classification of medulloblastoma.
Orr BA
Brain Pathol; 2020 May; 30(3):664-678. PubMed ID: 32239782
[TBL] [Abstract][Full Text] [Related]
12. Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease.
Ellison DW
Acta Neuropathol; 2010 Sep; 120(3):305-16. PubMed ID: 20652577
[TBL] [Abstract][Full Text] [Related]
13. Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification.
Korshunov A; Remke M; Werft W; Benner A; Ryzhova M; Witt H; Sturm D; Wittmann A; Schöttler A; Felsberg J; Reifenberger G; Rutkowski S; Scheurlen W; Kulozik AE; von Deimling A; Lichter P; Pfister SM
J Clin Oncol; 2010 Jun; 28(18):3054-60. PubMed ID: 20479417
[TBL] [Abstract][Full Text] [Related]
14. Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.
von Hoff K; Hartmann W; von Bueren AO; Gerber NU; Grotzer MA; Pietsch T; Rutkowski S
Pediatr Blood Cancer; 2010 Mar; 54(3):369-76. PubMed ID: 19908297
[TBL] [Abstract][Full Text] [Related]
15. Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation.
Cambruzzi E
Childs Nerv Syst; 2018 May; 34(5):809-815. PubMed ID: 29582169
[TBL] [Abstract][Full Text] [Related]
16. Expression of the neurotrophin receptor p75NTR in medulloblastomas is correlated with distinct histological and clinical features: evidence for a medulloblastoma subtype derived from the external granule cell layer.
Bühren J; Christoph AH; Buslei R; Albrecht S; Wiestler OD; Pietsch T
J Neuropathol Exp Neurol; 2000 Mar; 59(3):229-40. PubMed ID: 10744061
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging spectrum of medulloblastoma.
Fruehwald-Pallamar J; Puchner SB; Rossi A; Garre ML; Cama A; Koelblinger C; Osborn AG; Thurnher MM
Neuroradiology; 2011 Jun; 53(6):387-96. PubMed ID: 21279509
[TBL] [Abstract][Full Text] [Related]
18. Multiple genomic alterations including N-myc amplification in a primary large cell medulloblastoma.
Reardon DA; Jenkins JJ; Sublett JE; Burger PC; Kun LK
Pediatr Neurosurg; 2000 Apr; 32(4):187-91. PubMed ID: 10940769
[TBL] [Abstract][Full Text] [Related]
19. "Large cell/anaplastic" medulloblastomas: a Pediatric Oncology Group Study.
Brown HG; Kepner JL; Perlman EJ; Friedman HS; Strother DR; Duffner PK; Kun LE; Goldthwaite PT; Burger PC
J Neuropathol Exp Neurol; 2000 Oct; 59(10):857-65. PubMed ID: 11079775
[TBL] [Abstract][Full Text] [Related]
20. Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays.
Kagawa N; Maruno M; Suzuki T; Hashiba T; Hashimoto N; Izumoto S; Yoshimine T
Brain Tumor Pathol; 2006 Apr; 23(1):41-7. PubMed ID: 18095118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
